Dynamics of Oligoclonal Hematopoiesis in Severe Aplastic Anemia Patients Undergoing Immunosuppressive Treatment: Longitudinal Somatic Mutation Analysis from the EBMT Race Trial
D Kaya(King's College London), Ghulam Mufti(King's College London), Jean-Baptiste Méar, Giorgio Napolitani(University of Oxford), Flore Sicre de Fontbrune(Hôpital Saint-Louis), Morag Griffin(Leeds Teaching Hospitals NHS Trust), Riley Cook(Centre Hospitalier Universitaire de Toulouse), Marica Laurino(Hospices Civils de Lyon), Austin Kulasekararaj(King's College London), Fiorenza Barraco(Hôpital Lyon Sud), Antonio M. Risitano(European Society for Blood and Marrow Transplantation), Nogayhan Seymen(London Cancer), Camilla Frieri(Université Paris Cité), Sofie Terwel(Centre Hospitalier Universitaire de Toulouse), Mohammad M. Karimi(University of British Columbia), Régis Peffault de Latour(Hôpital Saint-Louis), Marleen van Os(Universität Hamburg), Beatrice Drexler(University Hospital of Basel), Édouard Forcade(Hôpital Cardiologique du Haut-Lévêque), Sıla Gerlevik(London Cancer), Etienne Daguindau(Hôpital Privé Jean Mermo), Carlo Dufour(Istituto Giannina Gaslini), Constantijn J.M. Halkes(Radboud University Nijmegen), S. Iacobelli(University of Rome Tor Vergata), Christian Récher(Institut universitaire du cancer de Toulouse Oncopole)
Cited by 2
Related Papers
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
|Nature Immunology|2020|1.4k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
Guidelines for the diagnosis and management of adult aplastic anaemia
|British Journal of Haematology|2015|750